Investigation Effect of losartan NAFLD patients

Phase 3

• Conditions: Fatty (change of) liver, not elsewhere classified; AFLD.; K76.0

• Registration Number: IRCT20180412039283N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

patients with pre hypertension and fatty liver

Exclusion Criteria

history of other liver diseases except fatty liver

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
iver functions tests. Timepoint: liver function tests before losartan and 12 weeks after losartan. Method of measurement: laboratory.